ACE and Decreased total neutrophil count: More specifically, the ongoing systemic treatment type (Supplementary Table 1), lymphopenia (< 0.5 G/L), neutropenia (< 1 G/L), and use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers had no significant prognostic impact (all p value > 0.6).